Le Lézard
Classified in: Health
Subjects: MAV, CMG, CFG

Media Advisory - Prime Minister's itinerary for Wednesday, February 22, 2023


OTTAWA, ON, Feb. 21, 2023 Note: All times local

York Region, Ontario



10:15 a.m.

The Prime Minister will participate in a discussion with personal support workers. He will be joined by the Minister of Seniors, Kamal Khera.




Note for media:


  • Pooled coverage at the beginning of the meeting


11:05 a.m.

The Prime Minister will hold a short media availability.




Notes for media:


  • Open coverage
  • Media are asked to arrive no later than 9:30 a.m.
  • Media interested in participating can contact [email protected] for details.


Longueuil, Quebec



2:00 p.m.

The Prime Minister will meet with the Mayor of Longueuil, Catherine Fournier.




Note for media:


  • Pooled photo opportunity at the beginning of the meeting


4:00 p.m.

The Prime Minister will participate in a town hall with farmers and agricultural producers.




Notes for media:


  • Open coverage
  • Media are asked to arrive no later than 3:15 p.m.
  • Media interested in participating can contact [email protected] for details.


This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 02:10
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Management Guidance for Revenue and Core EPS performance...

8 mai 2024
Tri-Tech expands emergency medical offering with the strategic acquisition of SAM Medical
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

More news about Health...


News published on and distributed by: